Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
594.8 USD | -0.39% | +0.10% | +11.84% |
Financials (USD)
Sales 2024 * | 43.01B | Sales 2025 * | 46.08B | Capitalization | 228B |
---|---|---|---|---|---|
Net income 2024 * | 6.15B | Net income 2025 * | 6.97B | EV / Sales 2024 * | 5.86 x |
Net Debt 2024 * | 23.99B | Net Debt 2025 * | 19.18B | EV / Sales 2025 * | 5.36 x |
P/E ratio 2024 * |
37.6
x | P/E ratio 2025 * |
32.2
x | Employees | 122,000 |
Yield 2024 * |
0.25% | Yield 2025 * |
0.27% | Free-Float | 86.04% |
Latest transcript on Thermo Fisher Scientific
1 day | -0.31% | ||
1 week | +3.33% | ||
Current month | +5.00% | ||
1 month | +7.68% | ||
3 months | +9.00% | ||
6 months | +26.39% | ||
Current year | +12.50% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 56 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 17 M€ | +7.73% | - | |
5.37% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 593.9 | -0.55% | 383 147 |
24-05-16 | 597.2 | -0.31% | 1,409,375 |
24-05-15 | 599 | +0.71% | 1,188,732 |
24-05-14 | 594.8 | +0.69% | 1,040,938 |
24-05-13 | 590.7 | -0.39% | 944,626 |
Delayed Quote Nyse, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.50% | 228B | |
+14.52% | 196B | |
+17.51% | 141B | |
+28.96% | 110B | |
+1.22% | 65.88B | |
+18.16% | 54.3B | |
+7.63% | 52.39B | |
+10.95% | 45.22B | |
+5.10% | 37.12B | |
+27.85% | 32.32B |
- Stock Market
- Equities
- TMO Stock